CNNC research in nuclear medicine

Nuclear medicine is an important means of tumor diagnosis and treatment. Under the guidance of the “Healthy China” strategy proposed by General Secretary Xi Jinping, CNNC gives full play to its advantages in the nuclear medical industry chain and makes nuclear technology application products and services more popular, better, and more convenient for the people through technological innovation. the General Hospital of Nuclear Industry of China Baoyuan, a subsidiary of CNNC, successfully carried out the interventional minimally invasive surgery of yttrium 23 resin microspheres for patients with advanced liver cancer in Suzhou, which means that the international advanced selective internal radiation therapy officially landed in Suzhou, which is a landmark advanced achievement in the field of liver cancer treatment of the General Hospital of Nuclear Industry and is of great significance to benefit liver cancer patients in Suzhou and even the whole country. It is also another vivid practice of CNNC to practice the social responsibility of central enterprises and escort the construction of “Healthy China”.